|
|
|
|
|
|
|
|
|
|
The Cancer Biomarker Conundrum: Too Many False Discoveries
14 Aug 2010
"The boom in cancer biomarker investments over the past 25 years has not translated into major clinical success. The reasons for biomarker failures include problems with study design and interpretation, as well as statistical deficiencies, according to an article published online August 12 in The Journal of the National Cancer Institute...".cont'd including several references to ovarian cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.